Evaluation of polymorphisms in paraoxonase 2 (PON2) gene and their association with cardiovascular-renal disease risk in Mexican Americans

Kidney and Blood Pressure Research

Volumn 32, Issue 3, 2009, Pages 200-204

  Thameem, Farook ^a   He, Xin ^a   Voruganti, V Saroja ^c   Nath, Subrata D ^a   Fanti, Paolo ^a,b   Blangero, John ^c   MacCluer, Jean W ^c   Comuzzie, Anthony G ^c   Arar, Nedal H ^a,b   Abboud, Hanna E ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Association analyses; Genetic polymorphisms; Mexican Americans; PON2; Systolic blood pressure

Indexed keywords

ARGININE; ARYLDIALKYLPHOSPHATASE 2; CYSTEINE; GLYCINE; SERINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HISPANIC; HUMAN; INTRON; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ARYLDIALKYLPHOSPHATASE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY DISEASES; MEXICAN AMERICANS; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 67449119052     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225943     Document Type: Article

References (28)

1. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE: Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 2003;8:1-12. (Pubitemid 36097533)
2. Mackness MI, Arrol S, Abbott CA, Durrington PN: Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein- associated paraoxonase. Atherosclerosis 1993;104:129-135. (Pubitemid 24035640)
3. Watson AD, Berliner JA, Hama SY, La Du BN, Fault K, Fogelman AM: Protective effect of high-density lipoprotein associated paraoxonase - inhibition of the biological activity of minimally oxidised low-density lipoprotein. J Clin Invest 1995;96:2882-2891.
4. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-1590. (Pubitemid 28198486)
5. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN: The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996;33:498-507. (Pubitemid 26159866)
6. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST: Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of lowdensity lipoprotein. J Biol Chem 2001;276:44444-44449. (Pubitemid 37391215)
7. Rosenblat M, Draganov D, Watson CE, Bisgaier CL, La Du BN, Aviram M: Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase-3 activity is decreased under oxidative stress. Arterioscler Thromb Vasc Biol 2003;23:468-474. (Pubitemid 36337224)
8. Hegele RA: Paraoxonase genes and disease. Ann Med 1999;31:217-224.
9. Pinizzotto M, Castillo E, Fiaux M, Tember E, Gaillard RC, Ruiz J: Paraoxonase-2 polymorphisms are associated with nephropathy in type 2 diabetes. Diabetologia 2001;44:104-107. (Pubitemid 32141891)
10. Hodgkinson AD, Millward BA, Demaine AG: Commentary to letter. Diabetologia 2002;45:933-935.
11. Canani LH, Araki S, Warram JH, Krolewski AS: Commentary to letter. Diabetologia 2001;44:1062-1069.
12. Kao Y, Donaghue KC, Chan A, Bennetts BH, Knight J, Silink M: Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes. Diabet Med 2002;19:212-215. (Pubitemid 34429651)
13. Sanghera DK, Aston CE, Saha N, Kamboh MI: DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet 1998;62:36-44. (Pubitemid 28093832)
14. Leus FR, Zwart M, Kastelein JJ, Voorbij HA: PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients. Atherosclerosis 2001;154:641-649. (Pubitemid 32232161)
15. Chen Q, Reis SE, Kammerer CM, McNamara DM, Holubkov R, Sharaf BL, Sopko G, Pauly DF, Merz CN, Kamboh MI;WISE Study Group: Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Am J Hum Genet 2003;72:13-22.
16. Martinelli N, Girelli D, Olivieri O, Stranieri C, Trabetti E, Pizzolo F, Friso S, Tenuti I, Cheng S, Grow MA, Pignatti PF, Corrocher R: Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction. Eur J Clin Invest 2004;34:14-20. (Pubitemid 38221734)
17. Calle R, McCarthy MI, Banerjee P, Zeggini E, Cull CA, Thorne KI, Wiltshire S, Terra S, Meyer D, Richmond J, Mancuso J, Milos P, Fryburg D, Holman RR: Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76. Diabetologia 2006;49:2892-2899. (Pubitemid 44730292)
18. Thameem F, Puppala S, Arar NH, Farook VS, Stern MP, Blangero J, Duggirala R, Abboud HE: The Cys(311)Ser polymorphism of paraoxonase 2 is associated with albumin-to-creatinine ratio in Mexican Americans. Nephrol Dial Transplant 2008;23:416-417.
19. MacCluer JW, Stern MP, Almasy L, Atwood LA, Blangero J, Comuzzie AG, Dyke B, Haffner SM, Henkel RD, Hixson JE, Kammerer CM, Mahaney MC, Mitchell BD, Rainwater DL, Samollow PB, Sharp RM, VandeBerg JL, Williams JT: Genetics of atherosclerosis risk factors in Mexican Americans. Nutr Rev 1999;57:S59-S65. (Pubitemid 29301214)
20. Arar NH, Voruganti VS, Nath SD, Thameem F, Bauer R, Cole SA, Blangero J, Maccluer JW, Comuzzie AG, Abboud HE: A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS. Nephrol Dial Transplant 2008;10:3184-3191.
21. Dyke B: PEDSYS, a Pedigree Data Management System. User's Manual. Population Genetics Laboratory Technical Report No. 2, ed 2. San Antonio, Southwest Foundation for Biomedical Research, 1994, pp 1-226.
22. Almasy L, Blangero J: Exploring positional candidate genes: linkage conditional on measured genotype. Behav Genet 2004;34:173-177. (Pubitemid 38268934)
23. Abecasis GR, Cookson WO, Cardon LR: Pedigree tests of transmission disequilibrium. Eur J Hum Genet 2000;8:545-551.
24. Havill LM, Dyer TD, Richardson DK, Mahaney MC, Blangero J: The quantitative trait linkage disequilibrium test: a more powerful alternative to the quantitative transmission disequilibrium test for use in the absence of population stratification. BMC Genet 2005;6:S91.
25. Puppala S, Dodd GD, Fowler S, Arya R, Schneider J, Farook VS, Granato R, Dyer TD, Almasy L, Jenkinson CP, Diehl AK, Stern MP, Blangero J, Duggirala R: A genome-wide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006;78:377-392. (Pubitemid 43291221)
26. Puppala S, Arya R, Thameem F, Arar NH, Bhandari K, Lehman DM, Schneider J, Fowler S, Farook VS, Diego VP, Almasy L, Blangero J, Stern MP, Duggirala R, Abboud HE: Genotype by diabetes interaction effects on the detection of linkage of glomerular filtration rate to a region on chromosome 2q in Mexican Americans. Diabetes 2007;56:2818-2828. (Pubitemid 350044926)
27. Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Saad MF, Scavini M, Smith MW, Taylor K, Winkler CA, Zager PG, Shah VO; Family Investigation of Nephropathy and Diabetes Research Group: Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 2008;57:235-243.
28. Freedman BI, Bowden DW, Rich SS, Xu J, Wagenknecht LE, Ziegler J, Hicks PJ, Langefeld CD: Genome-wide linkage scans for renal function and albuminuria in type 2 diabetes mellitus: the Diabetes Heart Study. Diabet Med 2008;25:268-276. (Pubitemid 351322699)